Noah Kahan's Face Value Exchange opened this week for ticket holders to The Great Divide Tour, six weeks ahead of the June 11 Orlando opener and eleven weeks after the February 12 general on-sale. [1] Tickets purchased on Ticketmaster are non-transferable; the resale page on Ticketmaster shows a single price column at the original face value; in the four states where transfer cannot legally be blocked — Illinois, New York, Colorado, Utah, Virginia, and Connecticut — Ticketmaster says it will honor Kahan's terms by capping the resale list price at face value on its own site. [2] [3]

The paper noted yesterday that face-value rules do not abolish scarcity when an $807 Boston seat was visible on a third-party listing. The exchange is the answer the tour gave to the question the secondary market kept asking. The argument is that the supply of returns inside the closed Ticketmaster system, listed at face, will absorb buyer demand before that demand walks to the third-party market. The policy this week is in evidence; the realized-price data is what the next six weeks will produce.

Kahan announced The Great Divide Tour on February 2 — 23 stadium dates produced by Live Nation, opening at Orlando's Kia Center and closing at Seattle's T-Mobile Park on August 30, with two-night homecomings at Boston's Fenway Park and stops at Wrigley Field, Citi Field, the Rose Bowl, Coors Field, and Toronto's Rogers Stadium. [4] Gigi Perez supports. The on-sale moved through an artist presale on February 10 and a general on-sale on February 12. Sign-up required a selfie or, in some cases, a Persona ID upload — Ticketmaster's third-party identity verification — to filter bots. The album of the same name dropped April 24 on Mercury. The exchange is the third operating layer.

What Wednesday's reader can see on the page is the discipline. A user listing a Fenway lower-bowl seat purchased at $179 cannot list at $400; Ticketmaster's exchange page surfaces only the face-value figure. The state-law carveouts in Illinois, New York, Colorado, Utah, Virginia, and Connecticut allow ticket transfer outside Ticketmaster, which means a Boston-area ticket holder cannot be barred from giving the seat to a friend or selling on a third-party platform. But the resale list inside Ticketmaster — the column the largest population of buyers reaches first — is capped. [3] [5]

The thesis Kahan and Ticketmaster have advanced is that the cap on the largest pool inside the system, combined with non-transferable mobile-only tickets and identity verification at presale, depresses the secondary-market premium below the threshold scalpers can profitably operate at. The thesis the paper has tracked across the tour is that scarcity does not dissolve under face-value rules; it migrates. A buyer willing to pay $400 for a $179 seat, when blocked from Ticketmaster's exchange, walks to a state where transfer is permitted, or to a non-Ticketmaster reseller, or to a friend-of-a-friend network. [6]

The data the next six weeks will produce — a stadium tour's daily exchange-listing volume, list-versus-sale-price ratios, geographic distribution of listings against the four-state legal carveout map — is the evidence the face-value frame has not yet had. Trade outlets including Pollstar and MusicRow covered the policy at announcement. [7] [8] Ticketmaster's own substack defended the policy with a piece titled "Why Noah Kahan is using Face Value Exchange." [1] None of those publications has yet pulled the realized-price page.

What the policy cannot do is change inventory. There are 23 stadium dates and a finite seat count; the marquee dates — Fenway, Wrigley, Citi Field, Rose Bowl — are the ones where the on-sale produced the steepest secondary-market premiums on third-party platforms before the exchange opened. The exchange's first inventory test is whether the listing volume on those dates is large enough to hold realized prices at face when fans who can't make the show start posting returns and fans who couldn't get on at on-sale start refreshing the page.

The Foo Fighters used a face-value model for their Bridgeport one-off Tuesday and a tour-launch face-value page is in motion. The Cure used a similar architecture in 2023, and the realized data showed that exchange-listed seats cleared at face for the largest portion of inventory. Kahan's case is bigger, longer, and the inventory is stadium-scale. Whether the exchange holds the line on a six-week stretch into a 23-date stadium run is the operational question this paper has been carrying. The answer is now arriving on a calendar.

-- CAMILLE BEAUMONT, Los Angeles